These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10029369)

  • 21. Liver support therapy: an overview of the AMC-bioartificial liver research.
    van de Kerkhove MP; Poyck PP; Deurholt T; Hoekstra R; Chamuleau RA; van Gulik TM
    Dig Surg; 2005; 22(4):254-64. PubMed ID: 16174982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional Evaluation of a Bioartificial Liver Support System Using Immobilized Hepatocyte Spheroids in a Porcine Model of Acute Liver Failure.
    Lee JH; Lee DH; Lee S; Kwon CHD; Ryu JN; Noh JK; Jang IK; Park HJ; Yoon HH; Park JK; Kim YJ; Kim SK; Lee SK
    Sci Rep; 2017 Jun; 7(1):3804. PubMed ID: 28630420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioartificial liver devices: Perspectives on the state of the art.
    Ding YT; Shi XL
    Front Med; 2011 Mar; 5(1):15-9. PubMed ID: 21088931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of a novel bioartificial liver in rats with complete liver ischemia: treatment efficacy and species-specific alpha-GST detection to monitor hepatocyte viability.
    Flendrig LM; Chamuleau RA; Maas MA; Daalhuisen J; Hasset B; Kilty CG; Doyle S; Ladiges NC; Jörning GG; la Soe JW; Sommeijer D; te Velde AA
    J Hepatol; 1999 Feb; 30(2):311-20. PubMed ID: 10068112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a bioartificial liver using isolated hepatocytes.
    Dixit V
    Artif Organs; 1994 May; 18(5):371-84. PubMed ID: 8037612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth and metabolic activity of immortalized porcine hepatocytes in extracorporeal hollow-fiber liver assist devices.
    Liu J; Jauregui HO; Faris RA; Santangini HA; Trenkler DM; Silva PG; Garcia KM
    Artif Organs; 2001 Jul; 25(7):539-45. PubMed ID: 11493274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Artificial liver support: state of the art.
    Dixit V; Gitnick G
    Scand J Gastroenterol Suppl; 1996; 220():101-14. PubMed ID: 8898446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of bioartificial and artificial liver support devices.
    Hughes RD; Williams R
    Semin Liver Dis; 1996 Nov; 16(4):435-44. PubMed ID: 9027956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioartificial liver support systems for acute liver failure: A systematic review and meta-analysis of the clinical and preclinical literature.
    He YT; Qi YN; Zhang BQ; Li JB; Bao J
    World J Gastroenterol; 2019 Jul; 25(27):3634-3648. PubMed ID: 31367162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioartificial liver treatment in rats with fulminant hepatic failure: effect on DNA-binding activity of liver-enriched and growth-associated transcription factors.
    Suh KS; Lilja H; Kamohara Y; Eguchi S; Arkadopoulos N; Neuman T; Demetriou AA; Rozga J
    J Surg Res; 1999 Aug; 85(2):243-50. PubMed ID: 10423325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioartificial liver systems: current status and future perspective.
    Park JK; Lee DH
    J Biosci Bioeng; 2005 Apr; 99(4):311-9. PubMed ID: 16233796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Internal bioartificial liver with xenogeneic hepatocytes prevents death from acute liver failure: an experimental study.
    Roger V; Balladur P; Honiger J; Baudrimont M; Delelo R; Robert A; Calmus Y; Capeau J; Nordlinger B
    Ann Surg; 1998 Jul; 228(1):1-7. PubMed ID: 9671059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolated hepatocytes in a bioartificial liver: A single group view and experience.
    Rozga J; Morsiani E; Lepage E; Moscioni AD; Demetriou AA; Giorgio T
    Biotechnol Bioeng; 1994 Mar; 43(7):645-53. PubMed ID: 18615764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Observation on hybrid bioartificial liver support systems in treating chronic severe hepatitis: a study of 60 cases].
    Luo HT; Liu QM; Tan JJ; Ye YN; Zhang PH; Luo ZD; Long H
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):205-9. PubMed ID: 16556417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ['Artificial support in case of hepatic failure'; a report from the Dutch Health Council].
    Chamuleau RA
    Ned Tijdschr Geneeskd; 2005 Jan; 149(5):221-3. PubMed ID: 15719830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a hollow fiber bioartificial liver device.
    Abu-Absi SF; Seth G; Narayanan RA; Groehler K; Lai P; Anderson ML; Sielaff T; Hu WS
    Artif Organs; 2005 May; 29(5):419-22. PubMed ID: 15854219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioartificial liver: its pros and cons.
    Chamuleau RA; Poyck PP; van de Kerkhove MP
    Ther Apher Dial; 2006 Apr; 10(2):168-74. PubMed ID: 16684219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioartificial liver support.
    Hui T; Rozga J; Demetriou AA
    J Hepatobiliary Pancreat Surg; 2001; 8(1):1-15. PubMed ID: 11294283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for Galalpha(1-3)Gal expression on primary porcine hepatocytes: implications for bioartificial liver systems.
    van de Kerkhove MP; Germans MR; Deurholt T; Hoekstra R; Joziasse DH; van Wijk AC; van Gulik TM; Chamuleau RA; Roos A
    J Hepatol; 2005 Apr; 42(4):541-7. PubMed ID: 15763340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracorporeal application of a gel-entrapment, bioartificial liver: demonstration of drug metabolism and other biochemical functions.
    Nyberg SL; Shirabe K; Peshwa MV; Sielaff TD; Crotty PL; Mann HJ; Remmel RP; Payne WD; Hu WS; Cerra FB
    Cell Transplant; 1993; 2(6):441-52. PubMed ID: 8167929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.